Japan’s Ministry of Health, Labour and Welfare approves GSK’s Arexvy, the country’s first respiratory syncytial virus (RSV) vaccine for older adults Read more
Valneva Announces New IXIARO Supply Contract with the U.S. Government Worth a Minimum of $32 Million Read more
Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Read more
JURA Bio Announces Partnership With Replay Product Company Syena to Advance T Cell Receptor NK Therapies in Cancer Read more
Debiopharm and SunRock Biopharma Partner to Advance Antibody Drug Conjugates for Hard-to-treat Cancers Read more
FDA Accepts for Priority Review Merck’s Supplemental New Drug Application for WELIREG (belzutifan) in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC) Read more